Immunoregulation in Idiopathic Inflammatory Myopathies: From Dendritic Cells to Immature Regenerating Muscle Cells

REFERENCES

1. 1.↵
   1. Hoogendijk JE,
   2. Amato AA,
   3. Lecky BR,
   4. Choy EH,
   5. Lundberg IE,
   6. Rose MR,
   7. et al.

   119th ENMC International Workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion-body myositis. Neuromuscul Disord 2004;14:337–45.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Troyanov Y,
   2. Targoff IN,
   3. Tremblay JL,
   4. Goulet JR,
   5. Raymond Y,
   6. Senecal JL

   . Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies. Analysis of 100 French Canadian patients. Medicine 2005;84: 231–49.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Gendek-Kubiak H,
   2. Gendek EG

   . Fascin-expressing dendritic cells dominate in polymyositis and dermatomyositis. J Rheumatol 2012;40:186.

   OpenUrl
4. 4.↵
   1. Greenberg SA,
   2. Pinkus GS,
   3. Amato AA,
   4. Pinkus JL

   . Myeloid dendritic cells in inclusion-body myositis and polymyositis. Muscle Nerve 2007;35:17–23.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Lopez de Padilla CM,
   2. Vallejo AN,
   3. McNallan KT,
   4. Vehe R,
   5. Smith SA,
   6. Dietz AB,
   7. et al.

   Plasmacytoid dendritic cells in inflamed muscle of patients with juvenile dermatomyositis. Arthritis Rheum 2007;56:1658–68.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Eloranta ML,
   2. Barbasso Helmers S,
   3. Ulfgren AK,
   4. Rönnblom L,
   5. Alm GV,
   6. Lundberg IE

   . A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52/anti-Ro 60 autoantibodies. Arthritis Rheum 2007;56:3112–24.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Page G,
   2. Chevrel G,
   3. Miossec P

   . Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: Interaction with chemokines and Th1 cytokine-producing cell. Arthritis Rheum 2004;50:199–208.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Tournadre A,
   2. Porcherot M,
   3. Chérin P,
   4. Marie I,
   5. Hachulla E,
   6. Miossec P

   . Th1 and Th17 balance in inflammatory myopathies: interaction with dendritic cells and possible link with response to high-dose immunoglobulins. Cytokine 2009;46:297–301.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Page G,
   2. Lebecque S,
   3. Miossec P

   . Anatomic localization of immature and mature dendritic cells in an ectopic lymphoid organ: correlation with selective chemokine expression in rheumatoid synovium. J Immunol 2002;168:5333–41.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Tournadre A,
    2. Miossec P

    . Cytokine response in inflammatory myopathies. Curr Rheumatol Rep 2007;9:286–90.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Hohlfeld R,
    2. Engel AG

    . Coculture with autologous myotubes of cytotoxic T cells isolated from muscle in inflammatory myopathies. Ann Neurol 1991;29:498–507.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Benveniste O,
    2. Chérin P,
    3. Maisonobe T,
    4. Merat R,
    5. Chosidow O,
    6. Mouthon L,
    7. et al.

    Severe perturbations of the blood T cell repertoire in polymyositis, but not dermatomyositis patients. J Immunol 2001;167:3521–9.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. Tournadre A,
    2. Lenief V,
    3. Eljaafari A,
    4. Miossec P

    . Immature muscle precursors are a source of interferon-beta in myositis: Role of Toll-like receptor 3 activation and contribution to HLA class I up-regulation. Arthritis Rheum 2012;64:533–41.

    OpenUrlPubMed
14. 14.↵
    1. Tucci M,
    2. Quatraro C,
    3. Dammacco F,
    4. Silvestris F

    . Interleukin-18 overexpression as a hallmark of the activity of autoimmune inflammatory myopathies. Clin Exp Immunol 2006;146:21–31.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Tournadre A,
    2. Miossec P

    . Interleukin-17 in inflammatory myopathies. Curr Rheumatol Rep 2012;14:252–6.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Casciola-Rosen L,
    2. Nagaraju K,
    3. Plotz P,
    4. Wang K,
    5. Levine S,
    6. Gabrielson E,
    7. et al.

    Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy. J Exp Med 2005;201:591–601.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Mammen AL,
    2. Chung T,
    3. Christopher-Stine L,
    4. Rosen P,
    5. Rosen A,
    6. Doering KR,
    7. et al.

    Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy. Arthritis Rheum 2011;63:713–21.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Tournadre A,
    2. Lenief V,
    3. Miossec P

    . Expression of Toll-like receptor 3 and Toll-like receptor 7 in muscle is characteristic of inflammatory myopathy and is differentially regulated by Th1 and Th17 cytokines. Arthritis Rheum 2010;62:2144–51.

    OpenUrlPubMed
19. 19.↵
    1. Walsh RJ,
    2. Kong SW,
    3. Yao Y,
    4. Jallal B,
    5. Kiener PA,
    6. Pinkus JL,
    7. et al.

    Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis. Arthritis Rheum 2007;56:3784–92.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Nagaraju K,
    2. Casciola-Rosen L,
    3. Lundberg I,
    4. Rawat R,
    5. Cutting S,
    6. Thapliyal R,
    7. et al.

    Activation of the endoplasmic reticulum stress response in autoimmune myositis: Potential role in muscle fiber damage and dysfunction. Arthritis Rheum 2005;52:1824–35.

    OpenUrlCrossRefPubMed